South Korea
· Delayed Price · Currency is KRW Chabiotech Co.,Ltd. Statistics
Total Valuation
Chabiotech Co.,Ltd. has a market cap or net worth of KRW 894.27 billion. The enterprise value is 1.57 trillion.
| Market Cap | 894.27B |
| Enterprise Value | 1.57T |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Chabiotech Co.,Ltd. has 56.31 million shares outstanding. The number of shares has increased by 0.38% in one year.
| Shares Outstanding | 56.31M |
| Shares Change (YoY) | +0.38% |
| Shares Change (QoQ) | +7.89% |
| Owned by Insiders (%) | 15.80% |
| Owned by Institutions (%) | 12.07% |
| Float | 41.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.92 |
| PB Ratio | 3.11 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -69.64 |
| EV / Sales | 1.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -16.23 |
Financial Position
The company has a current ratio of 0.73, with a Debt / Equity ratio of 71.16.
| Current Ratio | 0.73 |
| Quick Ratio | 0.63 |
| Debt / Equity | 71.16 |
| Debt / EBITDA | 211.83 |
| Debt / FCF | -5.20 |
| Interest Coverage | -1.17 |
Financial Efficiency
Return on equity (ROE) is -2.93% and return on invested capital (ROIC) is -1.95%.
| Return on Equity (ROE) | -2.93% |
| Return on Assets (ROA) | -1.26% |
| Return on Capital (ROIC) | -1.95% |
| Revenue Per Employee | 3.60B |
| Profits Per Employee | -82.96M |
| Employee Count | 271 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 20.73 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.46% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.46% |
| 50-Day Moving Average | 16,309.00 |
| 200-Day Moving Average | 17,163.40 |
| Relative Strength Index (RSI) | 42.80 |
| Average Volume (20 Days) | 376,751 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Chabiotech Co.,Ltd. had revenue of KRW 974.80 billion and -22.48 billion in losses. Loss per share was -499.31.
| Revenue | 974.80B |
| Gross Profit | 252.67B |
| Operating Income | -36.46B |
| Pretax Income | -15.98B |
| Net Income | -22.48B |
| EBITDA | 2.37B |
| EBIT | -36.46B |
| Loss Per Share | -499.31 |
Balance Sheet
The company has 248.50 billion in cash and 502.05 billion in debt, giving a net cash position of -253.55 billion or -4,502.40 per share.
| Cash & Cash Equivalents | 248.50B |
| Total Debt | 502.05B |
| Net Cash | -253.55B |
| Net Cash Per Share | -4,502.40 |
| Equity (Book Value) | 705.50B |
| Book Value Per Share | 5,109.65 |
| Working Capital | -226.16B |
Cash Flow
In the last 12 months, operating cash flow was 14.16 billion and capital expenditures -110.62 billion, giving a free cash flow of -96.47 billion.
| Operating Cash Flow | 14.16B |
| Capital Expenditures | -110.62B |
| Free Cash Flow | -96.47B |
| FCF Per Share | -1,713.04 |
Margins
Gross margin is 25.92%, with operating and profit margins of -3.74% and -2.39%.
| Gross Margin | 25.92% |
| Operating Margin | -3.74% |
| Pretax Margin | -1.64% |
| Profit Margin | -2.39% |
| EBITDA Margin | 0.24% |
| EBIT Margin | -3.74% |
| FCF Margin | -9.90% |
Dividends & Yields
Chabiotech Co.,Ltd. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.38% |
| Shareholder Yield | -0.38% |
| Earnings Yield | -3.14% |
| FCF Yield | -10.79% |
Stock Splits
The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.
| Last Split Date | Jun 2, 2014 |
| Split Type | Reverse |
| Split Ratio | 0.7262 |